BioInformant

Your Global Leader in Stem Cell Market Research

You are here: Home / Archives for Cord Blood

AAOSCP’s “Master Workshop” is Most Comprehensive Stem Cell Therapy Workshop

By

Never before has a workshop featured BM, SVF, UCB, Peptides, Cytokines and Exosomes under the same roof.

AAOSCPOn August 2-4, 2019, the American Academy of Stem Cell Physicians (AAOSCP) will host a Scientific Congress and Workshop, featuring Basic Science to Clinical Practice. Hosted at the Hyatt  Hotel in Miami, Florida, the event will involve the use of live patients to serve as a simulation of new techniques that utilize regenerative medicine as the primary treatment plan.

The AAOSCP is now hosting a major meeting every three months, because it is the only way to keep up with the constantly advancing field. [Read more…]

LifeCell International, India’s Largest Cord Blood Bank

By

LifeCell, India's No. 1 Cord Blood BankLifeCell is India’s largest cord blood bank, offering stem cell banking services and diagnostic testing. Established in 2004, its BabyCord program is one of the largest cord blood banking programs in the region, with 50,000+ parents preserving newborn stem cells each year and 375,000 units cryopreserved.

I had the honor of interviewing Mr. Mayur Abhaya Srisrimal, Chief Executive Officer and Managing Director of LifeCell. Mr. Abhaya has led LifeCell since 2008 and been instrumental in expanding its stem cell storage services across India with its BabyCord program. Under his leadership, LifeCell also raised growth capital from Helion Ventures and extended its preventive diagnostic services by launching BabyShield, a program targeted at reducing the infant mortality ratio. [Read more…]

ExCellThera enters into a manufacturing and collaboration agreement with New York Blood Center

By

MONTREAL, MAY 7, 2019 – ExCellThera Inc., an advanced clinical stage biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, announced today that it has entered into a manufacturing and collaboration agreement with Comprehensive Cell Solutions (CCS), a division of New York Blood Center (NYBC) for the clinical grade production of ExCellThera’s lead cell therapy product, ECT-001. [Read more…]

Famicord, Europe’s Largest Cord Blood Bank, and India’s CelluGen, Sign Letter of Intent

By

FamiCord Group, the largest cord blood bank in Europe, and CelluGen Biotech, a biotech company headquartered in Gurgaon, India, have signed a letter of intent (LOI) to cooperate across a range of business activities. Dated April 25, 2019, the specifics of the LOI state that the companies will pursue cooperation within the “field of family cord blood banking of stem cells and the use of stem cells in experimental and standard therapies.” The companies may jointly develop ATMPs and drugs. [Read more…]

ExCellThera’s Cell Expansion Technology, ECT-001, Receives FDA RMAT Designation

By

ExcelltheraMONTREAL, April 23, 2019 — ExCellThera Inc., an advanced clinical stage biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, announced today that the U.S. Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to its lead technology, ECT-001, in the treatment of hematologic malignancies. The RMAT designation is based on strong data from Phase I/II clinical trials using ECT-001 to expand stem and immune cells for the treatment of blood cancers. [Read more…]

BioInformant's World-Class Clients